May 2001 Volume 4, No. 5
		Focus: High Throughput Screening
MDD Home 2004 Issues Dec 2004 Nov 2004 Oct 2004 Sep 2004 Aug 2004 Jul 2004 Jun 2004 May 2004 Apr 2004 Mar 2004 Feb 2004 Jan 2004 03-00 Issues 2003 Issues 2002 Issues 2001 Issues 2000 Issues		Screening's age of insecurity Deborah J. Ausman High-throughput screening hasn’t given us more drugs. Can better data management make a difference? Diagnosis: Medicine Randall C. Willis and Mark S. Lesney From antibodies to e-noses, assay tests and kits aid in identifying diseases and prescribing drugs. Spotting a microarray system Elizabeth Zubritsky A broader array of commercial products edges out home-built systems. Living the high (throughput) life Mark S. Lesney HTS looks for rewards from the use of cellular assays.
	DEPARTMENTS
		Content in Context The nature of drugs From Our Readers News in Brief Promising primosomes Cancer risk assay Cancer survival vs hospital type Neutralizing neurotoxicity PTFE offers support Proteomic profiles of cancer Just a spoonful of sugar On aggression The Tool Box Protein-drug interaction Clinical Trials Track The investigational review process Diseases and Disorders Toxoplasmosis Patents and Property A Renaissance legacy The Time Line A brief history of pharmacology Ready to Read Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease For Your Health Reflections on obesity Sites and Software A river of data runs through it Money Matters: Corporate Cashing in on gene sequences On the Calendar New Product Notes